Connecticut is losing more bioscience jobs than it is gaining, despite a sizable jump in research and development jobs over the last three years. Alexion’s departure is the latest in a line that has undercut bioscience growth. Nonetheless, many say New Haven is nearing a “critical mass” after years of effort by Yale and a new cluster is emerging in Farmington after more than $1 billion in state investment.
Today is the second meeting of a task force established earlier this year by Gov. Dannel P. Malloy on Connecticut’s Certificate of Need (CoN) laws. Along with a parallel study by the Governor’s Health Care Cabinet, the task force is supposed to help formulate a 21st century body of laws to govern our complex healthcare system. The challenge to both bodies is to place at the center of every discussion the interests of patients; access, both geographic and financial, as well as outcomes.
Middlesex Hospital has reached a settlement with state regulators that will allow it to put a new piece of cancer treatment equipment in its shoreline clinic in Westbrook – a proposal that drew opposition from Yale-New Haven Hospital and sparked questions about the intersection of state regulation and health care competition.
As hospitals join larger systems and critics worry about access to care, a key legislator said the time is ripe for lawmakers to revisit the way the state regulates major changes in health care. But it’s not yet clear what shape such changes will take – or whether they would leave the state with more regulation or less, a sign of sharply differing views on its role.
What began with a plan to replace an aging piece of medical equipment has turned into a dispute over the delivery of cancer care along Connecticut’s affluent shoreline. And at a time when policymakers have expressed worries about preserving competition in the state’s fast-consolidating health care market, one side has suggested the case highlights questions about competition – and the way state regulation can limit it.
It is hard to turn on your computer or to check out your evening news without hearing highly paid hospital executives saying that the sky is falling and arguing that they are on the side of consumers. In reviewing the recent filings with state regulators, it appears that this may just be an effort to create a distraction as they go about radically changing the health care landscape in Connecticut. If unchecked it is likely to have a very harmful impact on cost and access.
WASHINGTON – President Obama’s move to ease the longstanding U.S. embargo on Cuba, including travel restrictions to the island, does not mean Connecticut residents can pack their bags for a new travel destination in the Caribbean. But it does make it easier to go for those who want to visit Cuba for an officially sanctioned reason.
Testing by the Centers for Disease Control and Prevention confirmed that the Yale graduate student hospitalized with Ebola-like symptoms does not have the virus, according to a Yale-New Haven Hospital official.
Preliminary testing indicates that the Yale doctoral student admitted to Yale-New Haven Hospital with Ebola-like symptoms does not have the deadly virus. While awaiting the results, officials sought to emphasize the efforts to prepare in case someone in Connecticut contracts Ebola virus — while also trying to reassure people that the risk of infection is low.
Updated 1:45 p.m.
A patient with Ebola-like symptoms was admitted to Yale-New Haven Hospital for evaluation late Wednesday night. “We have not confirmed or ruled-out any diagnosis at this point,” the hospital said in a statement.
The proposals restricting hospitals’ ability to become for-profit are unlikely to become law exactly as written. But they set the stage for what’s likely to be an intense debate about hospitals, fueled by the discomfort among many lawmakers about the way the health care system is changing.